Population-Based Validation of a German-Language Self-Administered Headache Questionnaire

Ms, Yoon; Obermann, Mark; Fritsche, G.; Slomke, M; Dommes, P; Schilf, C; Hc, Diener; Katsarava, Zaza

doi:10.1111/j.1468-2982.2008.01560.x

Cited by 45 publications

(66 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A false negative rate around 15% is compatible with the sensitivities of our questionnaire for MIG (0.73) and TTH (0.85) [4, 9]. …”

Section: Discussionsupporting

confidence: 81%

See 1 more Smart Citation

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study

Katsarava

Obermann

et al. 2012

J Headache Pain

Self Cite

View full text Add to dashboard Cite

We investigated the prevalence of migraine (MIG), tension-type headache (TTH), and chronic headache in a population-based sample in Germany. A total of 18,000 subjects aged between 18 and 65 years were screened from 2003 until 2005 using a validated questionnaire. Overall 9,944 participants (55.2%) responded (mean age 43 ± 13.1 years, 52.7% women). Headache frequency <15 days/month was reported by 5,350 (55.5%) subjects of whom 1,601 (16.6%, [95% confidence interval (95% CI): 15.9–17.4]) reported episodic MIG, 1,202 (12.5%, 95% CI 11.8–13.1) episodic TTH, and 1,150 (11.9%, [11.3–12.6]) episodic MIG + episodic TTH, 1,396 (14.5%, [13.8–15.2]) unclassifiable headache. In women, episodic MIG peaked between 36 and 40 years, episodic MIG + TTH between 18 and 35 years and episodic TTH between 56 and 66 years. In men, episodic MIG was predominant between 36 and 45 years, episodic MIG + TTH between 26 and 35 years and episodic TTH showed comparable frequency between 36 and 66 years. Headache ≥15 days/month was reported by 2.6% (n = 255, [95% CI 2.3–3]). Chronic MIG was reported by 1.1% (n = 108, [0.91–1.33]), chronic TTH (n = 50, [95% CI 0.4–0.7]), chronic MIG + TTH 0.8% (n = 74, 95% CI 0.6–0.9) and unclassifiable headache 0.2% (n = 23, [95% CI 0.1–0.3]). Chronic headache was more frequent in women compared to men with the highest prevalence between 46 and 65 years. It is of note that the number of subjects with chronic headache is small in all age groups. The results of our large, population-based study provide reliable, age- and sex-specific estimates of the prevalence of primary headache disorders in Germany. The prevalence with respect to episodic and chronic primary headache disorders in Germany is comparable to other European countries and the USA.

show abstract

“…A false negative rate around 15% is compatible with the sensitivities of our questionnaire for MIG (0.73) and TTH (0.85) [4, 9]. …”

Section: Discussionsupporting

confidence: 81%

“…The results of the validation were reported elsewhere [4, 9]. First, the participants were asked if they experienced any kind of headache in the last year.…”

Section: Methodsmentioning

confidence: 99%

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study

Katsarava

Obermann

et al. 2012

J Headache Pain

Self Cite

View full text Add to dashboard Cite

show abstract

“…The prevalence of headache (40%) and its predominant similarity to TTH (57%) obtained using a self-administered headache questionnaire [sensitivity and specificity of 0.85 and 0.85 for migraine and 0.6 and 0.88 for TTH, respectively (23)] is in accordance with the literature describing headache in 31-71% of patients with brain tumours (4)(5)(6)(7)(8). According to our definition, five patients were included as having a new headache (5/23, 22%) as they described an explicit alteration of their pain characteristics, although no change in headache syndrome according to the self-administered questionnaire was documented.…”

Section: Discussionmentioning

confidence: 99%

Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expression

Schankin¹,

Krumbholz

Sostak³

et al. 2009

Cephalalgia

View full text Add to dashboard Cite

We included 58 patients with meningioma in a prospective study to analyse the prevalence of and risk factors for different types of meningioma-associated headache. Twenty-three patients (40%) had meningioma-associated headache. Of these, the pain was migraine-like in five (22%) and tension-type headache (TTH)-like in 13 (57%). Sixteen of 21 (76%) experienced relief of pain intensity of at least 50% after 18-24 months. Univariate analysis revealed bone-invasive growth pattern (P = 0.007) as a risk factor for headache and intake of antiepileptic drugs (P = 0.04) or large surrounding oedema (P = 0.04) as possible protective parameters. For migraine-like headache, risk factors were a positive history of migraine (P = 0.009) and bone-invasive growth pattern (P = 0.046) and, for TTH-like headache, only bone-invasive growth pattern (P = 0.009). Binary logistic regression analysis added to assess predictability and interaction effects could not identify a single factor predicting the occurrence of headache in the presence of a meningioma (correct prediction in 74% by a model consisting of bone-invasive growth pattern, history of head surgery, intake of antiepileptic drugs, temporal tumour location and moderate and large surrounding oedema). Analysis of 38 tumour specimens could not confirm the hypothesis that the occurrence of headache correlates with the expression magnitude of signal substances known to be present in meningiomas [stroma cell-derived factor 1, interleukin (IL)-1β, IL-6, vascular endothelial growth factor A] or thought to be relevant to headache/pain pathophysiology [prostaglandin-endoperoxide synthase 2, calcitonin-related polypeptide alpha, nitric oxide synthase (NOS) 1, NOS2A, NOS3, transforming growth factor-alpha, tumour necrosis factor, tachykinin, vasoactive intestinal peptide]. The affection of bone integrity and the expression of molecules thought to be relevant to headache pathophysiology might be important for meningioma-associated headache in predisposed individuals.

show abstract

“…L'autoquestionnaire français ainsi que l'italien ont cependant le défaut d'avoir été validés sur des effectifs de patients suivis en centre tertiaire et de ne pas avoir été évalués sur des populations moins sélectionnés alors que ces questionnaires de dépistage sont censés être utilisé en soins primaires et même en population générale dans le cadre des études épi-démiologiques. Ainsi, un questionnaire générique allemand visant à dépister les grands types de céphalées primaires à partir des critères de la deuxième édition de la classification internationale des céphalées et validé sur un effectif de patients sélectionnés en centre tertiaire (grade B)[57] s'est avéré inopérant pour dépister les CTA (dont l'AVF) en population générale (grade B)[58]. Par contre, un travail hollandais récent a développé un auto-questionnaire de dépistage de l'AVF en considérant d'emblée une population moins sélectionnée recrutée à partir d'un site Internet dédié[59].…”

unclassified

Recommandations pour le diagnostic et le traitement de l’algie vasculaire de la face

Donnet

Demarquay

Ducros

et al. 2015

Douleurs : Evaluation - Diagnostic - Traitement

View full text Add to dashboard Cite

Population-Based Validation of a German-Language Self-Administered Headache Questionnaire

Cited by 45 publications

References 14 publications

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study

Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expression

Recommandations pour le diagnostic et le traitement de l’algie vasculaire de la face

Contact Info

Product

Resources

About